U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

We have entered the era where AI agents are making clinical decisions, automating claim denials and recommending care timelines.

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Vertical consolidation in healthcare has been a hot-button topic of late as regulators eye strategies to bring down ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

Amid abuses to consumers by big corporations, the Federal Trade Commission Act was passed in 1914. Antitrust enforcement by ...

The Federal Trade Commission in the US is planning to sue ... legal action against PBMs owned by UnitedHealth Group, CVS, and Cigna, claiming they have skewed the market by pushing patients ...

The inflated prices in the United States fuel global innovation while foreign health systems get a free ride.” ...